26th Jan 2016 14:38
LONDON (Alliance News) - Premaitha Health PLC on Tuesday said the first hearing on the claims lodged by US medical tools maker Illumina Inc will take place in March and the outcome should be known by Christmas this year.
Illumina has filed two patent infringement suits, one of which is against Premaitha's Polish customer and other of which it against The Doctors Laboratory in the UK, which is supplied by Ariosa Diagnostics, a subsidiary of Swiss pharmaceuticals group Roche AG.
Illumina has claimed the IONA test, Premaitha's non-invasive pre-natal testing device, infringes on its patents, which Premaitha has denied.
The first UK hearing will take place in March, with the proceedings in the case to take place in October and a final decision expected by Christmas, Premaitha said.
"We continue to defend these actions robustly and we remain focused on delivering patient choice through high quality non-invasive prenatal testing in the UK and internationally," said Stephen Little, Premaitha's chief executive.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Premaitha Health